BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care 2020;24:353. [PMID: 32546188 DOI: 10.1186/s13054-020-03062-7] [Cited by in Crossref: 162] [Cited by in F6Publishing: 146] [Article Influence: 81.0] [Reference Citation Analysis]
Number Citing Articles
1 Marchetti M, Gomez-Rosas P, Sanga E, Gamba S, Verzeroli C, Russo L, Restuccia F, Schieppati F, Bonanomi E, Rizzi M, Fagiuoli S, D'Alessio A, Lorini L, Falanga A. Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction. TH Open 2021;5:e253-63. [PMID: 34235394 DOI: 10.1055/s-0041-1731711] [Reference Citation Analysis]
2 Ergül E, Yılmaz AS, Öğütveren MM, Emlek N, Kostakoğlu U, Çetin M. COVID 19 disease independently predicted endothelial dysfunction measured by flow-mediated dilatation. Int J Cardiovasc Imaging 2021. [PMID: 34286447 DOI: 10.1007/s10554-021-02356-3] [Reference Citation Analysis]
3 Kaur S, Tripathi DM, Yadav A. The Enigma of Endothelium in COVID-19. Front Physiol 2020;11:989. [PMID: 32848893 DOI: 10.3389/fphys.2020.00989] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
4 Xu S, Liu Y, Ding Y, Luo S, Zheng X, Wu X, Liu Z, Ilyas I, Chen S, Han S, Little PJ, Jain MK, Weng J. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction. Signal Transduct Target Ther 2021;6:266. [PMID: 34253708 DOI: 10.1038/s41392-021-00690-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Trinity JD, Craig JC, Fermoyle CC, McKenzie AI, Lewis MT, Park SH, Rondina MT, Richardson RS. Impact of presymptomatic COVID-19 on vascular and skeletal muscle function: a case study. J Appl Physiol (1985) 2021;130:1961-70. [PMID: 34002634 DOI: 10.1152/japplphysiol.00236.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hollenberg MD, Epstein M. The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets. Kidney International Supplements 2022;12:48-62. [DOI: 10.1016/j.kisu.2021.12.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Moskvin S, Askhadulin E, Kochetkov A. Low-Level Laser Therapy in Prevention of the Development of Endothelial Dysfunction and Clinical Experience of Treatment and Rehabilitation of COVID-19 Patients. Rehabil Res Pract 2021;2021:6626932. [PMID: 33542837 DOI: 10.1155/2021/6626932] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 George JA, Mayne ES. The Novel Coronavirus and Inflammation. Adv Exp Med Biol 2021;1321:127-38. [PMID: 33656719 DOI: 10.1007/978-3-030-59261-5_11] [Reference Citation Analysis]
9 Townsend L, Moloney D, Finucane C, McCarthy K, Bergin C, Bannan C, Kenny RA. Fatigue following COVID-19 infection is not associated with autonomic dysfunction. PLoS One 2021;16:e0247280. [PMID: 33630906 DOI: 10.1371/journal.pone.0247280] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
10 Vincent JL, Wendon J, Martin GS, Juffermans NP, Creteur J, Cecconi M. COVID-19: What we've done well and what we could or should have done better-the 4 Ps. Crit Care 2021;25:40. [PMID: 33509218 DOI: 10.1186/s13054-021-03467-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Niknam Z, Jafari A, Golchin A, Danesh Pouya F, Nemati M, Rezaei-Tavirani M, Rasmi Y. Potential therapeutic options for COVID-19: an update on current evidence. Eur J Med Res 2022;27:6. [PMID: 35027080 DOI: 10.1186/s40001-021-00626-3] [Reference Citation Analysis]
12 Tong M, Chen F, Zheng Q, Zhu Y. Reply. J Infect Dis 2021;223:1499-500. [PMID: 33515453 DOI: 10.1093/infdis/jiab041] [Reference Citation Analysis]
13 Otifi HM, Adiga BK. Endothelial Dysfunction in Covid-19. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2021.12.010] [Reference Citation Analysis]
14 Pourafkari L, Mirza-Aghzadeh-Attari M, Zarrintan A, Mousavi-Aghdas SA. Clinical Experience, Pathophysiology, and Considerations in the Prophylaxis and Treatment of Hypercoagulopathy of COVID-19: A Review Study. Iran J Med Sci 2021;46:1-14. [PMID: 33487787 DOI: 10.30476/ijms.2020.87233.1730] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Barbosa LC, Gonçalves TL, de Araujo LP, Rosario LVO, Ferrer VP. Endothelial cells and SARS-CoV-2: An intimate relationship. Vascul Pharmacol 2021;137:106829. [PMID: 33422689 DOI: 10.1016/j.vph.2021.106829] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Manzano GS, McEntire CRS, Martinez-Lage M, Mateen FJ, Hutto SK. Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis. Neurol Neuroimmunol Neuroinflamm 2021;8:e1080. [PMID: 34452974 DOI: 10.1212/NXI.0000000000001080] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Willows S, Alam SB, Sandhu JK, Kulka M. A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis. Biochem Cell Biol 2021;99:173-94. [PMID: 33027600 DOI: 10.1139/bcb-2020-0341] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Alvarado-Vasquez N. Could a family history of type 2 diabetes be a risk factor to the endothelial damage in the patient with COVID-19? Med Hypotheses 2021;146:110378. [PMID: 33189452 DOI: 10.1016/j.mehy.2020.110378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Yatim N, Boussier J, Chocron R, Hadjadj J, Philippe A, Gendron N, Barnabei L, Charbit B, Szwebel TA, Carlier N, Pène F, Azoulay C, Khider L, Mirault T, Diehl JL, Guerin CL, Rieux-Laucat F, Duffy D, Kernéis S, Smadja DM, Terrier B. Platelet activation in critically ill COVID-19 patients. Ann Intensive Care 2021;11:113. [PMID: 34273008 DOI: 10.1186/s13613-021-00899-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Janes F, Gigli GL, Kuris F, Morassi M, Costa P, Nesi L, Giacomello R, Mazzacane F, Leuci E, Cavallini A, Valente M. Failure of Therapeutic Anticoagulation in COVID-19 Patients With Acute Ischemic Stroke. A Retrospective Multicenter Study. Front Neurol 2022;13:834469. [DOI: 10.3389/fneur.2022.834469] [Reference Citation Analysis]
21 Ghazanfar H, Kandhi S, Shin D, Muthumanickam A, Gurjar H, Qureshi ZA, Shaban M, Farag M, Haider A, Budhathoki P, Bhatt T, Ghazanfar A, Jyala A, Patel H. Impact of COVID-19 on the Gastrointestinal Tract: A Clinical Review. Cureus. [DOI: 10.7759/cureus.23333] [Reference Citation Analysis]
22 Deinhardt-Emmer S, Böttcher S, Häring C, Giebeler L, Henke A, Zell R, Jungwirth J, Jordan PM, Werz O, Hornung F, Brandt C, Marquet M, Mosig AS, Pletz MW, Schacke M, Rödel J, Heller R, Nietzsche S, Löffler B, Ehrhardt C. SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction. J Virol 2021:JVI. [PMID: 33637603 DOI: 10.1128/JVI.00110-21] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
23 Fan BE, Wong SW, Sum CLL, Lim GH, Leung BP, Tan CW, Ramanathan K, Dalan R, Cheung C, Lim XR, Sadasiv MS, Lye DC, Young BE, Yap ES, Chia YW; COVID-19 Clotting and Bleeding Investigators. Hypercoagulability, endotheliopathy, and inflammation approximating 1 year after recovery: Assessing the long-term outcomes in COVID-19 patients. Am J Hematol 2022. [PMID: 35477923 DOI: 10.1002/ajh.26575] [Reference Citation Analysis]
24 Queiroz CO, Conceição AF, Aristides PRS, Alves LS, Almeida RT. Physical Activity, Obesity, and COVID-19: What can we Expect from his Relationship? International Journal of Cardiovascular Sciences 2021. [DOI: 10.36660/ijcs.20200174] [Reference Citation Analysis]
25 Aparisi Á, Iglesias-Echeverría C, Ybarra-Falcón C, Cusácovich I, Uribarri A, García-Gómez M, Ladrón R, Fuertes R, Candela J, Tobar J, Hinojosa W, Dueñas C, González R, Nogales L, Calvo D, Carrasco-Moraleja M, San Román JA, Amat-Santos IJ, Andaluz-Ojeda D. Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19. Nutr Metab Cardiovasc Dis 2021;31:2619-27. [PMID: 34353699 DOI: 10.1016/j.numecd.2021.06.016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Roedl K, Jarczak D, Fischer M, Haddad M, Boenisch O, de Heer G, Burdelski C, Frings D, Sensen B, Karakas M, Kluge S, Nierhaus A. MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19. Biomarkers 2021;26:417-24. [PMID: 33754916 DOI: 10.1080/1354750X.2021.1905067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Nassau DE, Best JC, Kresch E, Gonzalez DC, Khodamoradi K, Ramasamy R. Impact of the SARS-CoV-2 virus on male reproductive health. BJU Int 2021. [PMID: 34402155 DOI: 10.1111/bju.15573] [Reference Citation Analysis]
28 Rovas A, Osiaevi I, Buscher K, Sackarnd J, Tepasse PR, Fobker M, Kühn J, Braune S, Göbel U, Thölking G, Gröschel A, Pavenstädt H, Vink H, Kümpers P. Microvascular dysfunction in COVID-19: the MYSTIC study. Angiogenesis 2021;24:145-57. [PMID: 33058027 DOI: 10.1007/s10456-020-09753-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 17.0] [Reference Citation Analysis]
29 Synowiec A, Szczepański A, Barreto-Duran E, Lie LK, Pyrc K. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection. Clin Microbiol Rev 2021;34:e00133-20. [PMID: 33441314 DOI: 10.1128/CMR.00133-20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
30 Cen G, Liu L, Wang J, Wang X, Chen S, Song Y, Liang Z. Weighted Gene Co-Expression Network Analysis to Identify Potential Biological Processes and Key Genes in COVID-19-Related Stroke. Oxid Med Cell Longev 2022;2022:4526022. [PMID: 35557984 DOI: 10.1155/2022/4526022] [Reference Citation Analysis]
31 Vuorio A, Strandberg TE, Raal F, Santos RD, Kovanen PT. Familial hypercholesterolemia and COVID-19: A menacing but treatable vasculopathic condition. Atheroscler Plus 2021;43:3-6. [PMID: 34622243 DOI: 10.1016/j.athplu.2021.08.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Liu J, Tu C, Zhu M, Wang J, Yang C, Liu W, Xiong B. The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study. Medicine (Baltimore) 2021;100:e23996. [PMID: 33663044 DOI: 10.1097/MD.0000000000023996] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
33 Manivannan J, Sundaresan L. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study. Gene Rep 2021;25:101312. [PMID: 34401607 DOI: 10.1016/j.genrep.2021.101312] [Reference Citation Analysis]
34 Udrea A, Mernea M, Buiu C, Avram S. Scutellaria baicalensis Flavones as Potent Drugs against Acute Respiratory Injury during SARS-CoV-2 Infection: Structural Biology Approaches. Processes 2020;8:1468. [DOI: 10.3390/pr8111468] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Karmouty-Quintana H, Thandavarayan RA, Keller SP, Sahay S, Pandit LM, Akkanti B. Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets. Int J Mol Sci 2020;21:E8081. [PMID: 33138181 DOI: 10.3390/ijms21218081] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
36 Ambrosino P, Calcaterra I, Molino A, Moretta P, Lupoli R, Spedicato GA, Papa A, Motta A, Maniscalco M, Di Minno MND. Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome: A Case-Control Study. Biomedicines 2021;9:957. [PMID: 34440161 DOI: 10.3390/biomedicines9080957] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Alay H, Laloglu E. The role of angiopoietin-2 and surfactant protein-D levels in SARS-CoV-2-related lung injury: A prospective, observational, cohort study. J Med Virol 2021;93:6008-15. [PMID: 34232533 DOI: 10.1002/jmv.27184] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 le Roux CW. COVID-19 alters thinking and management in metabolic diseases. Nat Rev Endocrinol 2021;17:71-2. [PMID: 33239662 DOI: 10.1038/s41574-020-00449-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
39 Afshar-Oromieh A, Prosch H, Schaefer-Prokop C, Bohn KP, Alberts I, Mingels C, Thurnher M, Cumming P, Shi K, Peters A, Geleff S, Lan X, Wang F, Huber A, Gräni C, Heverhagen JT, Rominger A, Fontanellaz M, Schöder H, Christe A, Mougiakakou S, Ebner L. A comprehensive review of imaging findings in COVID-19 - status in early 2021. Eur J Nucl Med Mol Imaging 2021;48:2500-24. [PMID: 33932183 DOI: 10.1007/s00259-021-05375-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
40 Deng H, Tang TX, Chen D, Tang LS, Yang XP, Tang ZH. Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies. Pathogens 2021;10:582. [PMID: 34064553 DOI: 10.3390/pathogens10050582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Deek SA. BPC 157 as Potential Treatment for COVID-19. Med Hypotheses 2021;158:110736. [PMID: 34798584 DOI: 10.1016/j.mehy.2021.110736] [Reference Citation Analysis]
42 [DOI: 10.1101/2020.08.27.20183442] [Cited by in Crossref: 44] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
43 Qian Y, Lei T, Patel PS, Lee CH, Monaghan-Nichols P, Xin HB, Qiu J, Fu M. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin. J Virol 2021;95:e0139621. [PMID: 34549987 DOI: 10.1128/JVI.01396-21] [Reference Citation Analysis]
44 Kohansal Vajari M, Shirin M, Pourbagheri-Sigaroodi A, Akbari ME, Abolghasemi H, Bashash D. COVID-19-related coagulopathy: A review of pathophysiology and pharmaceutical management. Cell Biol Int 2021. [PMID: 33945651 DOI: 10.1002/cbin.11623] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
45 Fernández S, Palomo M, Molina P, Díaz-Ricart M, Escolar G, Téllez A, Seguí F, Ventosa H, Torramade-Moix S, Rovira M, Carreras E, Nicolás JM, Castro P. Progressive endothelial cell damage in correlation with sepsis severity. Defibrotide as a contender. J Thromb Haemost 2021;19:1948-58. [PMID: 33872468 DOI: 10.1111/jth.15343] [Reference Citation Analysis]
46 Iba T, Levy JH. The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia. Trends Cardiovasc Med 2021:S1050-1738(21)00096-7. [PMID: 34455073 DOI: 10.1016/j.tcm.2021.08.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
47 Gerotziafas GT, Catalano M, Colgan MP, Pecsvarady Z, Wautrecht JC, Fazeli B, Olinic DM, Farkas K, Elalamy I, Falanga A, Fareed J, Papageorgiou C, Arellano RS, Agathagelou P, Antic D, Auad L, Banfic L, Bartolomew JR, Benczur B, Bernardo MB, Boccardo F, Cifkova R, Cosmi B, De Marchi S, Dimakakos E, Dimopoulos MA, Dimitrov G, Durand-Zaleski I, Edmonds M, El Nazar EA, Erer D, Esponda OL, Gresele P, Gschwandtner M, Gu Y, Heinzmann M, Hamburg NM, Hamadé A, Jatoi NA, Karahan O, Karetova D, Karplus T, Klein-Weigel P, Kolossvary E, Kozak M, Lefkou E, Lessiani G, Liew A, Marcoccia A, Marshang P, Marakomichelakis G, Matuska J, Moraglia L, Pillon S, Poredos P, Prior M, Salvador DRK, Schlager O, Schernthaner G, Sieron A, Spaak J, Spyropoulos A, Sprynger M, Suput D, Stanek A, Stvrtinova V, Szuba A, Tafur A, Vandreden P, Vardas PE, Vasic D, Vikkula M, Wennberg P, Zhai Z; Scientific Reviewer Committee. Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine. Thromb Haemost 2020;120:1597-628. [PMID: 32920811 DOI: 10.1055/s-0040-1715798] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 21.0] [Reference Citation Analysis]
48 Agus M, Ferrara ME, Bianco P, Manieli C, Mura P, Sechi R, Runfola M, Polo F, Cillara N. Atraumatic Splenic Rupture in a SARS-CoV-2 Patient: Case Report and Review of Literature. Case Rep Surg 2021;2021:5553619. [PMID: 34194865 DOI: 10.1155/2021/5553619] [Reference Citation Analysis]
49 Muhammad Abrar Jeelani H, Sheikh MM, Samuel SS, Omotosho YB, Sharko A, Albetar R. Acute Pancreatitis in a Patient With COVID-19 After the Resolution of Respiratory Symptoms. J Investig Med High Impact Case Rep 2021;9:23247096211024773. [PMID: 34130536 DOI: 10.1177/23247096211024773] [Reference Citation Analysis]
50 Gambardella J, Khondkar W, Morelli MB, Wang X, Santulli G, Trimarco V. Arginine and Endothelial Function. Biomedicines 2020;8:E277. [PMID: 32781796 DOI: 10.3390/biomedicines8080277] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
51 Flores-Pliego A, Miranda J, Vega-Torreblanca S, Valdespino-Vázquez Y, Helguera-Repetto C, Espejel-Nuñez A, Borboa-Olivares H, Espino Y Sosa S, Mateu-Rogell P, León-Juárez M, Ramírez-Santes V, Cardona-Pérez A, Villegas-Mota I, Torres-Torres J, Juárez-Reyes Á, Rizo-Pica T, González RO, González-Mariscal L, Estrada-Gutierrez G. Molecular Insights into the Thrombotic and Microvascular Injury in Placental Endothelium of Women with Mild or Severe COVID-19. Cells 2021;10:364. [PMID: 33578631 DOI: 10.3390/cells10020364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Pannone G, Caponio VCA, De Stefano IS, Ramunno MA, Meccariello M, Agostinone A, Pedicillo MC, Troiano G, Zhurakivska K, Cassano T, Bizzoca ME, Papagerakis S, Buonaguro FM, Advani S, Muzio LL. Lung histopathological findings in COVID-19 disease - a systematic review. Infect Agent Cancer 2021;16:34. [PMID: 34001199 DOI: 10.1186/s13027-021-00369-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Manenti A, Farinetti A, Manco G, Mattioli A. Vasculitis and aortitis: COVID-19 challenging complications. J Vasc Surg 2021;73:347-8. [PMID: 32889075 DOI: 10.1016/j.jvs.2020.08.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
54 Kaynar M, Gomes ALQ, Sokolakis I, Gül M. Tip of the iceberg: erectile dysfunction and COVID-19. Int J Impot Res. [DOI: 10.1038/s41443-022-00540-0] [Reference Citation Analysis]
55 Logette E, Lorin C, Favreau C, Oshurko E, Coggan JS, Casalegno F, Sy MF, Monney C, Bertschy M, Delattre E, Fonta PA, Krepl J, Schmidt S, Keller D, Kerrien S, Scantamburlo E, Kaufmann AK, Markram H. A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19. Front Public Health 2021;9:695139. [PMID: 34395368 DOI: 10.3389/fpubh.2021.695139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Sabioni L, De Lorenzo A, Lamas C, Muccillo F, Castro-Faria-Neto HC, Estato V, Tibirica E. Systemic microvascular endothelial dysfunction and disease severity in COVID-19 patients: Evaluation by laser Doppler perfusion monitoring and cytokine/chemokine analysis. Microvasc Res 2021;134:104119. [PMID: 33278457 DOI: 10.1016/j.mvr.2020.104119] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
57 Yamaoka-Tojo M. Vascular Endothelial Glycocalyx Damage in COVID-19. Int J Mol Sci 2020;21:E9712. [PMID: 33352699 DOI: 10.3390/ijms21249712] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
58 Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol 2020;16:636-44. [PMID: 32839585 DOI: 10.1038/s41582-020-0398-3] [Cited by in Crossref: 112] [Cited by in F6Publishing: 122] [Article Influence: 56.0] [Reference Citation Analysis]
59 Landolfo M, Maino A, Di Salvo E, Fiorini G, Peterlana D, Borghi C. Renin–angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study. Intern Emerg Med. [DOI: 10.1007/s11739-022-02929-7] [Reference Citation Analysis]
60 Fodor A, Tiperciuc B, Login C, Orasan OH, Lazar AL, Buchman C, Hanghicel P, Sitar-Taut A, Suharoschi R, Vulturar R, Cozma A. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets. Oxid Med Cell Longev 2021;2021:8671713. [PMID: 34457119 DOI: 10.1155/2021/8671713] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Hui KP, Cheung MC, Lai KL, Ng KC, Ho JC, Peiris M, Nicholls JM, Chan MC. Role of epithelial-endothelial cell interaction in the pathogenesis of SARS-CoV-2 infection. Clin Infect Dis 2021:ciab406. [PMID: 33956935 DOI: 10.1093/cid/ciab406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
62 Mishra R, Behera LM, Rana S. Binding of raloxifene to human complement fragment 5a (hC5a): a perspective on cytokine storm and COVID19. J Biomol Struct Dyn 2020;:1-13. [PMID: 32930050 DOI: 10.1080/07391102.2020.1820381] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Li J, Liu B. The roles and potential therapeutic implications of C5a in the pathogenesis of COVID-19-associated coagulopathy. Cytokine Growth Factor Rev 2021;58:75-81. [PMID: 33558131 DOI: 10.1016/j.cytogfr.2020.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
64 Maccio U, Zinkernagel AS, Shambat SM, Zeng X, Cathomas G, Ruschitzka F, Schuepbach RA, Moch H, Varga Z. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBioMedicine 2021;63:103182. [PMID: 33422990 DOI: 10.1016/j.ebiom.2020.103182] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
65 Bendjelid K, Giraud R, Von Düring S. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better? Anaesth Crit Care Pain Med 2020;39:451-2. [PMID: 32653550 DOI: 10.1016/j.accpm.2020.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
66 Vrints CJM, Krychtiuk KA, Van Craenenbroeck EM, Segers VF, Price S, Heidbuchel H. Endothelialitis plays a central role in the pathophysiology of severe COVID-19 and its cardiovascular complications. Acta Cardiol 2021;76:109-24. [PMID: 33208052 DOI: 10.1080/00015385.2020.1846921] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
67 du Preez HN, Aldous C, Hayden MR, Kruger HG, Lin J. Pathogenesis of COVID-19 described through the lens of an undersulfated and degraded epithelial and endothelial glycocalyx. FASEB J 2022;36:e22052. [PMID: 34862979 DOI: 10.1096/fj.202101100RR] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Tomar BS, Singh M, Nathiya D, Sharma A, Sharma E, Bareth H, Suman S, Ruparelia DP, Patel JB, Gajera VK; NIMS COVID 19 Investigator Group. Prevalence of Symptoms in Patients Discharged from COVID Care Facility of NIMS Hospital: Is RT PCR Negativity Truly Reflecting Recovery? A Single-Centre Observational Study. Int J Gen Med 2021;14:1069-78. [PMID: 33790636 DOI: 10.2147/IJGM.S295499] [Reference Citation Analysis]
69 Parthasarathy U, Martinelli R, Vollmann EH, Best K, Therien AG. The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders. Biochem Pharmacol 2022;195:114847. [PMID: 34801526 DOI: 10.1016/j.bcp.2021.114847] [Reference Citation Analysis]
70 Crisan-Dabija R, Pavel CA, Popa IV, Tarus A, Burlacu A. "A Chain Only as Strong as Its Weakest Link": An Up-to-Date Literature Review on the Bidirectional Interaction of Pulmonary Fibrosis and COVID-19. J Proteome Res 2020;19:4327-38. [PMID: 32883081 DOI: 10.1021/acs.jproteome.0c00387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
71 Iwanski J, Kazmouz SG, Li S, Stansfield B, Salem TT, Perez-Miller S, Kazui T, Jena L, Uhrlaub JL, Lick S, Nikolich-Žugich J, Konhilas JP, Gregorio CC, Khanna M, Campos SK, Churko JM. Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells. Stem Cell Reports 2021;16:2459-72. [PMID: 34525378 DOI: 10.1016/j.stemcr.2021.08.018] [Reference Citation Analysis]
72 Abobaker A, Alzwi A, Alraied AHA. Overview of the possible role of vitamin C in management of COVID-19. Pharmacol Rep 2020;72:1517-28. [PMID: 33113146 DOI: 10.1007/s43440-020-00176-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
73 Mezoh G, Crowther NJ. Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection. Adv Exp Med Biol 2021;1321:33-43. [PMID: 33656711 DOI: 10.1007/978-3-030-59261-5_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Yoganandamoorthy S, Munasinghe MADSN, Wanigasuriya LVU, Priyankara MKK, Jayasinghe S. Non-invasive assessment of endothelial dysfunction: A novel method to predict severe COVID-19? Med Hypotheses 2020;144:110229. [PMID: 33254535 DOI: 10.1016/j.mehy.2020.110229] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Nopp S, Moik F, Jilma B, Pabinger I, Ay C. Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis. Res Pract Thromb Haemost 2020. [PMID: 33043231 DOI: 10.1002/rth2.12439] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 41.5] [Reference Citation Analysis]
76 Ahmad Malik J, Ahmed S, Shinde M, Hajjaj Saeid Al-marmash M, Alghamdi S, Hussain A, Anwar S. The impact of COVID-19 on the comorbidities: A review of recent updates for combating it. Saudi Journal of Biological Sciences 2022. [DOI: 10.1016/j.sjbs.2022.02.006] [Reference Citation Analysis]
77 Lu T, Wu Y, Chen W, Hung Y, Yu Q. Targeting Oxidative Stress and Endothelial Dysfunction Using Tanshinone IIA for the Treatment of Tissue Inflammation and Fibrosis. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/2811789] [Reference Citation Analysis]
78 Sackner MA, Adams JA. Endothelial pulsatile shear stress is a backstop for COVID-19. Emerg Top Life Sci 2020;4:379-87. [PMID: 33200786 DOI: 10.1042/ETLS20200260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Frediansyah A. The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review. Clin Epidemiol Glob Health 2021;12:100826. [PMID: 34222718 DOI: 10.1016/j.cegh.2021.100826] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Ankola AA, Bradford VR, Newburger JW, Emani S, Dionne A, Friedman K, Son MB, Henderson LA, Lee PY, Hellinger A, Hawkins B, Ventresco C, Esteso P, VanderPluym CJ. Coagulation profiles and viscoelastic testing in multisystem inflammatory syndrome in children. Pediatr Blood Cancer 2021;68:e29355. [PMID: 34532964 DOI: 10.1002/pbc.29355] [Reference Citation Analysis]
81 de Matos BTL, Buchaim DV, Pomini KT, Barbalho SM, Guiguer EL, Reis CHB, Bueno CRS, Cunha MRD, Pereira ESBM, Buchaim RL. Photobiomodulation Therapy as a Possible New Approach in COVID-19: A Systematic Review. Life (Basel) 2021;11:580. [PMID: 34207199 DOI: 10.3390/life11060580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Madureira G, Soares R. The misunderstood link between SARS-CoV-2 and angiogenesis. A narrative review. Pulmonology 2021:S2531-0437(21)00160-4. [PMID: 34593362 DOI: 10.1016/j.pulmoe.2021.08.004] [Reference Citation Analysis]
83 Morello S, Caiazzo E, Turiello R, Cicala C. Thrombo-Inflammation: A Focus on NTPDase1/CD39. Cells 2021;10:2223. [PMID: 34571872 DOI: 10.3390/cells10092223] [Reference Citation Analysis]
84 Loo J, Spittle DA, Newnham M. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax 2021;76:412-20. [PMID: 33408195 DOI: 10.1136/thoraxjnl-2020-216243] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 25.0] [Reference Citation Analysis]
85 Rodriguez-Nakamura RM, Gonzalez-Calatayud M, Martinez Martinez AR. Acute mesenteric thrombosis in two patients with COVID-19. Two cases report and literature review. Int J Surg Case Rep 2020;76:409-14. [PMID: 33083204 DOI: 10.1016/j.ijscr.2020.10.040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
86 Hage R, Steinack C, Gautschi F, Pfister S, Inci I, Schuurmans MM. Clinical Characteristics, Treatments and Outcomes of 18 Lung Transplant Recipients with COVID-19. Transplantology 2021;2:229-45. [DOI: 10.3390/transplantology2020022] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 Gao Y, Galis ZS. Exploring the Role of Endothelial Cell Resilience in Cardiovascular Health and Disease. Arterioscler Thromb Vasc Biol 2021;41:179-85. [PMID: 33086867 DOI: 10.1161/ATVBAHA.120.314346] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
88 Li F, Li J, Wang PH, Yang N, Huang J, Ou J, Xu T, Zhao X, Liu T, Huang X, Wang Q, Li M, Yang L, Lin Y, Cai Y, Chen H, Zhang Q. SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling. Biochim Biophys Acta Mol Basis Dis 2021;1867:166260. [PMID: 34461258 DOI: 10.1016/j.bbadis.2021.166260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
89 Taieb P, Szekely Y, Lupu L, Ghantous E, Borohovitz A, Sadon S, Lichter Y, Ben-Gal Y, Banai A, Hochstadt A, Merdler I, Sapir O, Granot Y, Laufer-Perl M, Banai S, Topilsky Y. Risk prediction in patients with COVID-19 based on haemodynamic assessment of left and right ventricular function. Eur Heart J Cardiovasc Imaging 2021;22:1241-54. [PMID: 34453517 DOI: 10.1093/ehjci/jeab169] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
90 Quenzer F, Smyres C, Tabarez N, Singh S, LaFree A, Tomaszewski C, Hayden SR. Large Cerebellar Stroke in a Young COVID-19-Positive Patient: Case Report. J Emerg Med 2021;61:29-36. [PMID: 33863570 DOI: 10.1016/j.jemermed.2021.02.004] [Reference Citation Analysis]
91 Inal J. COVID-19 comorbidities, associated procoagulant extracellular vesicles and venous thromboembolisms: a possible link with ethnicity? Br J Haematol 2020;190:e218-20. [PMID: 32645205 DOI: 10.1111/bjh.17011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
92 Mitsuyama K, Tsuruta K, Takedatsu H, Yoshioka S, Morita M, Niwa M, Matsumoto S. Clinical Features and Pathogenic Mechanisms of Gastrointestinal Injury in COVID-19. J Clin Med. 2020;9:3630. [PMID: 33187280 DOI: 10.3390/jcm9113630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
93 Hattori Y, Hattori K, Machida T, Matsuda N. Vascular endotheliitis associated with infections: its pathogenetic role and therapeutic implication. Biochem Pharmacol 2022;:114909. [PMID: 35021044 DOI: 10.1016/j.bcp.2022.114909] [Reference Citation Analysis]
94 Saichi M, Ladjemi MZ, Korniotis S, Rousseau C, Ait Hamou Z, Massenet-Regad L, Amblard E, Noel F, Marie Y, Bouteiller D, Medvedovic J, Pène F, Soumelis V. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity. Nat Cell Biol 2021;23:538-51. [PMID: 33972731 DOI: 10.1038/s41556-021-00681-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
95 Warkentin TE, Kaatz S. COVID-19 versus HIT hypercoagulability. Thromb Res 2020;196:38-51. [PMID: 32841919 DOI: 10.1016/j.thromres.2020.08.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
96 Wagner JUG, Bojkova D, Shumliakivska M, Luxán G, Nicin L, Aslan GS, Milting H, Kandler JD, Dendorfer A, Heumueller AW, Fleming I, Bibli SI, Jakobi T, Dieterich C, Zeiher AM, Ciesek S, Cinatl J, Dimmeler S. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants. Basic Res Cardiol 2021;116:42. [PMID: 34224022 DOI: 10.1007/s00395-021-00882-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Nori S, Moran A, Franolich J, Patel J, Stern M. COVID-19 and Neurologic Manifestations: An Experience at Major New York City Hospitals. Cureus. [DOI: 10.7759/cureus.24049] [Reference Citation Analysis]
98 Denton CP, Campochiaro C, Bruni C, Distler O, Iagnocco A, Matucci Cerinic M. COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic. Journal of Scleroderma and Related Disorders 2021;6:58-65. [DOI: 10.1177/2397198320963393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
99 Hupf J, Mustroph J, Hanses F, Evert K, Maier LS, Jungbauer CG. RNA-expression of adrenomedullin is increased in patients with severe COVID-19. Crit Care 2020;24:527. [PMID: 32859259 DOI: 10.1186/s13054-020-03246-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
100 Ahmad S, Manzoor S, Siddiqui S, Mariappan N, Zafar I, Ahmad A, Ahmad A. Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19. Semin Cancer Biol 2021:S1044-579X(21)00008-0. [PMID: 33484868 DOI: 10.1016/j.semcancer.2021.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
101 Demoule A, Morawiec E, Decavele M, Ohayon R, Malrin R, Galarza-jimenez MA, Laveneziana P, Morelot-panzini C, Similowski T, De Rycke Y, Gonzalez-bermejo J. Health-related quality of life of COVID-19 two and 12 months after intensive care unit admission. Ann Intensive Care 2022;12. [DOI: 10.1186/s13613-022-00991-0] [Reference Citation Analysis]
102 Le Stang MB, Desenclos J, Flamant M, Chousterman BG, Tabibzadeh N. The Good Treatment, the Bad Virus, and the Ugly Inflammation: Pathophysiology of Kidney Involvement During COVID-19. Front Physiol 2021;12:613019. [PMID: 33776785 DOI: 10.3389/fphys.2021.613019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Khanna NN, Maindarkar M, Saxena A, Ahluwalia P, Paul S, Srivastava SK, Cuadrado-godia E, Sharma A, Omerzu T, Saba L, Mavrogeni S, Turk M, Laird JR, Kitas GD, Fatemi M, Barqawi AB, Miner M, Singh IM, Johri A, Kalra MM, Agarwal V, Paraskevas KI, Teji JS, Fouda MM, Pareek G, Suri JS. Cardiovascular/Stroke Risk Assessment in Patients with Erectile Dysfunction—A Role of Carotid Wall Arterial Imaging and Plaque Tissue Characterization Using Artificial Intelligence Paradigm: A Narrative Review. Diagnostics 2022;12:1249. [DOI: 10.3390/diagnostics12051249] [Reference Citation Analysis]
104 Stenmark KR, Frid MG, Gerasimovskaya E, Zhang H, McCarthy MK, Thurman JM, Morrison TE. Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement. Pulm Circ 2021;11:20458940211015799. [PMID: 34046161 DOI: 10.1177/20458940211015799] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
105 Lumpuy-Castillo J, Lorenzo-Almorós A, Pello-Lázaro AM, Sánchez-Ferrer C, Egido J, Tuñón J, Peiró C, Lorenzo Ó. Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System. Int J Mol Sci 2020;21:E6471. [PMID: 32899833 DOI: 10.3390/ijms21186471] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
106 Battaglini D, Brunetti I, Anania P, Fiaschi P, Zona G, Ball L, Giacobbe DR, Vena A, Bassetti M, Patroniti N, Schenone A, Pelosi P, Rocco PRM, Robba C. Neurological Manifestations of Severe SARS-CoV-2 Infection: Potential Mechanisms and Implications of Individualized Mechanical Ventilation Settings. Front Neurol 2020;11:845. [PMID: 32903391 DOI: 10.3389/fneur.2020.00845] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
107 Jacob CO. On the genetics and immunopathogenesis of COVID-19. Clin Immunol 2020;220:108591. [PMID: 32920210 DOI: 10.1016/j.clim.2020.108591] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
108 Melkumyants A, Buryachkovskaya L, Lomakin N, Antonova O, Docenko J, Ermishkin V, Serebruany V. Effect of Sulodexide on Circulating Blood Cells in Patients with Mild COVID-19. JCM 2022;11:1995. [DOI: 10.3390/jcm11071995] [Reference Citation Analysis]
109 Narayan P, Angelini GD. Vascular emergencies-The new COVID-19 crisis? J Card Surg 2021;36:2913-5. [PMID: 33000468 DOI: 10.1111/jocs.15072] [Reference Citation Analysis]
110 García de Guadiana-Romualdo L, Martínez Martínez M, Rodríguez Mulero MD, Esteban-Torrella P, Hernández Olivo M, Alcaraz García MJ, Campos-Rodríguez V, Sancho-Rodríguez N, Galindo Martínez M, Alcaraz A, Ros Braquehais MS, Báguena Perez-Crespo C, Ramos Arenas V, Tomás Jiménez C, Consuegra-Sánchez L, Conesa-Hernandez A, Piñera-Salmerón P, Bernal-Morell E. Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients. Int J Infect Dis 2021;111:211-8. [PMID: 34461254 DOI: 10.1016/j.ijid.2021.08.058] [Reference Citation Analysis]
111 Parsons S, Tran VL. The Trilogy of SARS-CoV-2 in Pediatrics (Part 1): Acute COVID-19 in Special Populations. J Pediatr Pharmacol Ther 2021;26:220-39. [PMID: 33833623 DOI: 10.5863/1551-6776-26.3.220] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Giraud R, Legouis D, Assouline B, De Charriere A, Decosterd D, Brunner ME, Moret-Bochatay M, Fumeaux T, Bendjelid K. Timing of VV-ECMO therapy implementation influences prognosis of COVID-19 patients. Physiol Rep 2021;9:e14715. [PMID: 33527751 DOI: 10.14814/phy2.14715] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
113 Waite AAC, Hamilton DO, Pizzi R, Ageno W, Welters ID. Hypercoagulopathy in Severe COVID-19: Implications for Acute Care. Thromb Haemost 2020;120:1654-67. [PMID: 33368088 DOI: 10.1055/s-0040-1721487] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
114 Alyammahi SK, Abdin SM, Alhamad DW, Elgendy SM, Altell AT, Omar HA. The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence, mechanisms and therapeutic modalities. Infect Genet Evol 2021;87:104647. [PMID: 33264669 DOI: 10.1016/j.meegid.2020.104647] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
115 Andrade FB, Gualberto A, Rezende C, Percegoni N, Gameiro J, Hottz ED. The Weight of Obesity in Immunity from Influenza to COVID-19. Front Cell Infect Microbiol 2021;11:638852. [PMID: 33816341 DOI: 10.3389/fcimb.2021.638852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
116 Qian Y, Lei T, Patel PS, Lee CH, Monaghan-Nichols P, Xin HB, Qiu J, Fu M. Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin. bioRxiv 2021:2021. [PMID: 33594363 DOI: 10.1101/2021.02.14.431174] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
117 Tarnawski AS, Ahluwalia A. Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs. World J Gastroenterol 2022;28:275-89. [PMID: 35110950 DOI: 10.3748/wjg.v28.i3.275] [Reference Citation Analysis]
118 Gressens SB, Leftheriotis G, Dussaule JC, Flamant M, Levy BI, Vidal-Petiot E. Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic. Front Physiol 2021;12:624052. [PMID: 33692701 DOI: 10.3389/fphys.2021.624052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
119 da Silva Ramos FJ, de Freitas FGR, Machado FR. Sepsis in patients hospitalized with coronavirus disease 2019: how often and how severe? Curr Opin Crit Care 2021;27:474-9. [PMID: 34292175 DOI: 10.1097/MCC.0000000000000861] [Reference Citation Analysis]
120 Wijeratne T, Wijeratne C, Karimi L, Sales C, Crewther SG. Case Report: Posterior Reversible Leukoencephalopathy Syndrome (PRES) as a Biologically Predictable Neurological Association in Severe COVID-19. First Reported Case From Australia and Review of Internationally Published Cases. Front Neurol 2020;11:600544. [PMID: 33584499 DOI: 10.3389/fneur.2020.600544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Sansone A, Mollaioli D, Ciocca G, Colonnello E, Limoncin E, Balercia G, Jannini EA. "Mask up to keep it up": Preliminary evidence of the association between erectile dysfunction and COVID-19. Andrology 2021;9:1053-9. [PMID: 33742540 DOI: 10.1111/andr.13003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
122 Rotoli BM, Barilli A, Visigalli R, Ferrari F, Dall'Asta V. Endothelial Cell Activation by SARS-CoV-2 Spike S1 Protein: A Crosstalk between Endothelium and Innate Immune Cells. Biomedicines 2021;9:1220. [PMID: 34572407 DOI: 10.3390/biomedicines9091220] [Reference Citation Analysis]
123 Saad HM, GamalEl Din SF, Elbokl OM, Adel A. Predictive factors of erectile dysfunction in Egyptian individuals after contracting COVID-19: A prospective case-control study. Andrologia 2021;:e14308. [PMID: 34773422 DOI: 10.1111/and.14308] [Reference Citation Analysis]
124 Svensson P, Hofmann R, Häbel H, Jernberg T, Nordberg P. Association between cardiometabolic disease and severe COVID-19: a nationwide case-control study of patients requiring invasive mechanical ventilation. BMJ Open 2021;11:e044486. [PMID: 33597145 DOI: 10.1136/bmjopen-2020-044486] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
125 Acevedo L, Piñeres-Olave BE, Niño-Serna LF, Vega LM, Gomez IJA, Chacón S, Jaramillo-Bustamante JC, Mulett-Hoyos H, González-Pardo O, Zemanate E, Izquierdo L, Mejìa JP, González JLJ, Duran BG, Gonzalez CB, Preciado H, Marun RO, Alvarez-Olmos MI, Alzate CG, Rojas J, Salazar-Uribe JC, Anaya JM, Fernández-Sarmiento J. Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study). BMC Pediatr 2021;21:516. [PMID: 34794410 DOI: 10.1186/s12887-021-02974-9] [Reference Citation Analysis]
126 Mutneja HR, Bhurwal A, Arora S, Goel A, Vohra I, Attar BM. Acute pancreatitis in patients with COVID-19 is more severe and lethal: a systematic review and meta-analysis. Scand J Gastroenterol 2021;56:1467-72. [PMID: 34465256 DOI: 10.1080/00365521.2021.1971757] [Reference Citation Analysis]
127 Galganska H, Jarmuszkiewicz W, Galganski L. Carbon dioxide inhibits COVID-19-type proinflammatory responses through extracellular signal-regulated kinases 1 and 2, novel carbon dioxide sensors. Cell Mol Life Sci 2021;78:8229-42. [PMID: 34741187 DOI: 10.1007/s00018-021-04005-3] [Reference Citation Analysis]
128 Vavougios GD, Ntoskas KT, Doskas TK. Impairment in selenocysteine synthesis as a candidate mechanism of inducible coagulopathy in COVID-19 patients. Med Hypotheses 2021;147:110475. [PMID: 33421689 DOI: 10.1016/j.mehy.2020.110475] [Reference Citation Analysis]
129 Khodeir MM, Shabana HA, Rasheed Z, Alkhamiss AS, Khodeir M, Alkhowailed MS, Alharbi S, Alsoghair M, Alsagaby SA, Al Abdulmonem W. COVID-19: Post-recovery long-term symptoms among patients in Saudi Arabia. PLoS One 2021;16:e0260259. [PMID: 34879074 DOI: 10.1371/journal.pone.0260259] [Reference Citation Analysis]
130 de la Morena-Barrio ME, Bravo-Pérez C, Miñano A, de la Morena-Barrio B, Fernandez-Perez MP, Bernal E, Gómez-Verdu JM, Herranz MT, Vicente V, Corral J, Lozano ML. Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients. Sci Rep 2021;11:7792. [PMID: 33833254 DOI: 10.1038/s41598-021-85906-y] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
131 Gupta NA, Lien C, Iv M. Critical illness-associated cerebral microbleeds in severe COVID-19 infection. Clin Imaging 2020;68:239-41. [PMID: 32911311 DOI: 10.1016/j.clinimag.2020.08.029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
132 Ito T, Kakuuchi M, Maruyama I. Endotheliopathy in septic conditions: mechanistic insight into intravascular coagulation. Crit Care 2021;25:95. [PMID: 33685461 DOI: 10.1186/s13054-021-03524-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Sansone A, Mollaioli D, Ciocca G, Limoncin E, Colonnello E, Vena W, Jannini EA. Addressing male sexual and reproductive health in the wake of COVID-19 outbreak. J Endocrinol Invest 2021;44:223-31. [PMID: 32661947 DOI: 10.1007/s40618-020-01350-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 15.0] [Reference Citation Analysis]
134 Guven G, Ince C, Topeli A, Caliskan K. Cardio-Pulmonary-Renal Consequences of Severe COVID-19. Cardiorenal Med 2021;11:133-9. [PMID: 34082420 DOI: 10.1159/000516740] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
135 Henry BM, de Oliveira MHS, Cheruiyot I, Benoit JL, Cooper DS, Lippi G, Le Cras TD, Benoit SW. Circulating level of Angiopoietin-2 is associated with acute kidney injury in coronavirus disease 2019 (COVID-19). Angiogenesis 2021;24:403-6. [PMID: 33755876 DOI: 10.1007/s10456-021-09782-w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
136 Gonzalez I, Lindner C, Schneider I, Morales MA, Rojas A. Inflammation at the crossroads of Helicobacter pylori and COVID-19. Future Microbiol 2022;17:77-80. [PMID: 34915742 DOI: 10.2217/fmb-2021-0250] [Reference Citation Analysis]
137 Rossetti M, Martucci G, Starchl C, Amrein K. Micronutrients in Sepsis and COVID-19: A Narrative Review on What We Have Learned and What We Want to Know in Future Trials. Medicina (Kaunas) 2021;57:419. [PMID: 33925791 DOI: 10.3390/medicina57050419] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Babkina AS, Ostrova IV, Yadgarov MY, Kuzovlev AN, Grechko AV, Volkov AV, Golubev AM. The Role of Von Willebrand Factor in the Pathogenesis of Pulmonary Vascular Thrombosis in COVID-19. Viruses 2022;14:211. [DOI: 10.3390/v14020211] [Reference Citation Analysis]
139 Jensen MP, Le Quesne J, Officer-Jones L, Teodòsio A, Thaventhiran J, Ficken C, Goddard M, Smith C, Menon D, Allinson KSJ. Neuropathological findings in two patients with fatal COVID-19. Neuropathol Appl Neurobiol 2021;47:17-25. [PMID: 32895961 DOI: 10.1111/nan.12662] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
140 Gusev E, Sarapultsev A, Hu D, Chereshnev V. Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes). Int J Mol Sci 2021;22:7582. [PMID: 34299201 DOI: 10.3390/ijms22147582] [Reference Citation Analysis]
141 Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol 2021;268:3059-71. [PMID: 33486564 DOI: 10.1007/s00415-021-10406-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
142 Louw S, Jacobson BF, Mayne ES, Wiggill TM. The Novel Coronavirus and Haemostatic Abnormalities: Pathophysiology, Clinical Manifestations, and Treatment Recommendations. Adv Exp Med Biol 2021;1321:173-80. [PMID: 33656723 DOI: 10.1007/978-3-030-59261-5_15] [Reference Citation Analysis]
143 Sharma D, Gupta S, Tomar DS. Non-hypertension-associated Posterior Reversible Encephalopathy Syndrome in COVID-19. Indian Journal of Critical Care Medicine 2022;26:639-40. [DOI: 10.5005/jp-journals-10071-24218] [Reference Citation Analysis]
144 Lewis KE, Stoll A, Watts S, Kirkman E. Relating Ventilatory Support and Drug Treatment Strategies to the Fundamental Pathophysiology in COVID-19 Illness. EMJ. [DOI: 10.33590/emj/20-00267] [Reference Citation Analysis]
145 Soumya RS, Unni TG, Raghu KG. Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports. Cardiovasc Drugs Ther 2021;35:411-25. [PMID: 32926272 DOI: 10.1007/s10557-020-07073-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
146 Daniels LB, Ren J, Kumar K, Bui QM, Zhang J, Zhang X, Sawan MA, Eisen H, Longhurst CA, Messer K. Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry. PLoS One 2021;16:e0254635. [PMID: 34264974 DOI: 10.1371/journal.pone.0254635] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
147 Tang X, Zheng F. A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms. Neurol Sci 2021. [PMID: 34671854 DOI: 10.1007/s10072-021-05679-0] [Reference Citation Analysis]
148 Targosz-Korecka M, Kubisiak A, Kloska D, Kopacz A, Grochot-Przeczek A, Szymonski M. Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors. Sci Rep 2021;11:12157. [PMID: 34108510 DOI: 10.1038/s41598-021-91231-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
149 Li C, Wang C, Zhang Y, Alsrouji OK, Chebl AB, Ding G, Jiang Q, Mayer SA, Lu M, Kole MK, Marin HL, Zhang L, Chopp M, Zhang ZG. Cerebral endothelial cell-derived small extracellular vesicles enhance neurovascular function and neurological recovery in rat acute ischemic stroke models of mechanical thrombectomy and embolic stroke treatment with tPA. J Cereb Blood Flow Metab 2021;41:2090-104. [PMID: 33557693 DOI: 10.1177/0271678X21992980] [Reference Citation Analysis]
150 Rauti R, Shahoha M, Leichtmann-Bardoogo Y, Nasser R, Paz E, Tamir R, Miller V, Babich T, Shaked K, Ehrlich A, Ioannidis K, Nahmias Y, Sharan R, Ashery U, Maoz BM. Effect of SARS-CoV-2 proteins on vascular permeability. Elife 2021;10:e69314. [PMID: 34694226 DOI: 10.7554/eLife.69314] [Reference Citation Analysis]
151 Volino-Souza M, de Oliveira GV, Conte-Junior CA, Alvares TS. Covid-19 Quarantine: Impact of Lifestyle Behaviors Changes on Endothelial Function and Possible Protective Effect of Beetroot Juice. Front Nutr 2020;7:582210. [PMID: 33195371 DOI: 10.3389/fnut.2020.582210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
152 Favaron E, Ince C, Hilty MP, Ergin B, van der Zee P, Uz Z, Wendel Garcia PD, Hofmaenner DA, Acevedo CT, van Boven WJ, Akin S, Gommers D, Endeman H. Capillary Leukocytes, Microaggregates, and the Response to Hypoxemia in the Microcirculation of Coronavirus Disease 2019 Patients. Crit Care Med 2021;49:661-70. [PMID: 33405410 DOI: 10.1097/CCM.0000000000004862] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
153 Nikolic M, Simovic S, Novkovic L, Jokovic V, Djokovic D, Muric N, Bazic Sretenovic D, Jovanovic J, Pantic K, Cekerevac I. Obesity and sleep apnea as a significant comorbidities in COVID-19 - A case report. Obes Res Clin Pract 2021;15:281-4. [PMID: 33933379 DOI: 10.1016/j.orcp.2021.04.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 Ateş O, Yıldırım M, Yıldırım K. Branch Retinal Artery Occlusion in Patient with COVID-19: Case Report. Korean J Ophthalmol 2021;35:484-5. [PMID: 34488254 DOI: 10.3341/kjo.2021.0008] [Reference Citation Analysis]
155 Agarwal L, Agarwal A, Advani S, Katiyar V, Chaturvedi A, Madhusudhan KS. The eyes see what the mind seeks: a systematic review of abdominal imaging findings in patients with COVID-19. Br J Radiol 2021;94:20201220. [PMID: 34260323 DOI: 10.1259/bjr.20201220] [Reference Citation Analysis]
156 Bernard I, Limonta D, Mahal LK, Hobman TC. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19. Viruses 2020;13:E29. [PMID: 33375371 DOI: 10.3390/v13010029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
157 Vincent JL. COVID-19: it's all about sepsis. Future Microbiol 2021;16:131-3. [PMID: 33491491 DOI: 10.2217/fmb-2020-0312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Behzadifard M, Soleimani M. NETosis and SARS-COV-2 infection related thrombosis: a narrative review. Thrombosis J 2022;20. [DOI: 10.1186/s12959-022-00375-1] [Reference Citation Analysis]
159 Bakker J, Horowitz JM, Hagedorn J, Kozloff S, Kaufman D, Castro R. Blood volume and albumin transudation in critically ill COVID-19 patients. Crit Care 2021;25:269. [PMID: 34332641 DOI: 10.1186/s13054-021-03699-y] [Reference Citation Analysis]
160 Matucci-Cerinic M, Hughes M, Taliani G, Kahaleh B. Similarities between COVID-19 and systemic sclerosis early vasculopathy: A "viral" challenge for future research in scleroderma. Autoimmun Rev 2021;20:102899. [PMID: 34274540 DOI: 10.1016/j.autrev.2021.102899] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
161 Ganesh B, Rajakumar T, Malathi M, Manikandan N, Nagaraj J, Santhakumar A, Elangovan A, Malik YS. Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives. Clin Epidemiol Glob Health 2021;10:100694. [PMID: 33462564 DOI: 10.1016/j.cegh.2020.100694] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
162 Karampitsakos T, Malakounidou E, Papaioannou O, Dimakopoulou V, Zarkadi E, Katsaras M, Tsiri P, Tsirikos G, Georgiopoulou V, Oikonomou I, Davoulos C, Velissaris D, Sampsonas F, Marangos M, Akinosoglou K, Tzouvelekis A. Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study. Respir Res 2021;22:317. [PMID: 34937570 DOI: 10.1186/s12931-021-01914-6] [Reference Citation Analysis]
163 Bunch CM, Moore EE, Moore HB, Neal MD, Thomas AV, Zackariya N, Zhao J, Zackariya S, Brenner TJ, Berquist M, Buckner H, Wiarda G, Fulkerson D, Huff W, Kwaan HC, Lankowicz G, Laubscher GJ, Lourens PJ, Pretorius E, Kotze MJ, Moolla MS, Sithole S, Maponga TG, Kell DB, Fox MD, Gillespie L, Khan RZ, Mamczak CN, March R, Macias R, Bull BS, Walsh MM. Immuno-Thrombotic Complications of COVID-19: Implications for Timing of Surgery and Anticoagulation. Front Surg 2022;9:889999. [DOI: 10.3389/fsurg.2022.889999] [Reference Citation Analysis]
164 Jakovac H. COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse outcome? Am J Physiol Heart Circ Physiol 2020;319:H793-6. [PMID: 32886002 DOI: 10.1152/ajpheart.00506.2020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
165 Rezkalla SH, Kloner RA. Viral myocarditis: 1917-2020: From the Influenza A to the COVID-19 pandemics. Trends Cardiovasc Med 2021;31:163-9. [PMID: 33383171 DOI: 10.1016/j.tcm.2020.12.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
166 Yadav P, Vats R, Bano A, Bhardwaj R. Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics.Life Sci. 2020;263:118588. [PMID: 33049279 DOI: 10.1016/j.lfs.2020.118588] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
167 Anastasiou G, Hatziagelaki E, Liberopoulos E. Could Dapagliflozin Attenuate COVID-19 Progression in High-Risk Patients With or Without Diabetes? Behind DARE-19 Concept. J Cardiovasc Pharmacol 2021;78:e12-9. [PMID: 34001719 DOI: 10.1097/FJC.0000000000001011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Belvitch P, Casanova N, Sun X, Camp SM, Sammani S, Brown ME, Mascarhenas J, Lynn H, Adyshev D, Siegler J, Desai A, Seyed-Saadat L, Rizzo A, Bime C, Shekhawat GS, Dravid VP, Reilly JP, Jones TK, Feng R, Letsiou E, Meyer NJ, Ellis N, Garcia JGN, Dudek SM. A cortactin CTTN coding SNP contributes to lung vascular permeability and inflammatory disease severity in African descent subjects. Transl Res 2022:S1931-5244(22)00022-6. [PMID: 35181549 DOI: 10.1016/j.trsl.2022.02.002] [Reference Citation Analysis]
169 Martos-Benítez FD, Soler-Morejón CD, García-Del Barco D. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico. Intern Emerg Med 2021;16:1507-17. [PMID: 33411264 DOI: 10.1007/s11739-020-02597-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
170 Tripathy AS, Vishwakarma S, Trimbake D, Gurav YK, Potdar VA, Mokashi ND, Patsute SD, Kaushal H, Choudhary ML, Tilekar BN, Sarje P, Dange VS, Abraham P. Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection. Arch Virol 2021. [PMID: 34554303 DOI: 10.1007/s00705-021-05247-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Sanz Segura P, Arguedas Lázaro Y, Mostacero Tapia S, Cabrera Chaves T, Sebastián Domingo JJ. Involvement of the digestive system in covid-19. A review. Gastroenterol Hepatol 2020;43:464-71. [PMID: 32859408 DOI: 10.1016/j.gastrohep.2020.06.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
172 Baron MV, Santos MPD, Werle TM, Scherer GDLG, Santos MMD, Dominguez LML, Brandenburg C, Feltez G, Sampaio AR, de Mello Pinto MV, Carvalho S, Meyer PF, Picariello F, Pacheco EF, Reinheimer IC, Sancho AG, da Costa BEP. Does COVID-19 infection increase the risk of pressure injury in critically ill patients?: A narrative review. Medicine (Baltimore) 2022;101:e29058. [PMID: 35356924 DOI: 10.1097/MD.0000000000029058] [Reference Citation Analysis]
173 Gao Y, Zhou W, Huang P, Liu H, Bi X, Zhu Y, Sun J, Tang Q, Li L, Zhang J, Zhu W, Cheng X, Liu Y, Deng Y. Persistent Endothelial Dysfunction in Coronavirus Disease-2019 Survivors Late After Recovery. Front Med 2022;9:809033. [DOI: 10.3389/fmed.2022.809033] [Reference Citation Analysis]
174 Montrucchio G, Lupia T, Lombardo D, Stroffolini G, Corcione S, De Rosa FG, Brazzi L. Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements. Ann Intensive Care 2021;11:136. [PMID: 34524562 DOI: 10.1186/s13613-021-00923-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Vollenberg R, Tepasse PR, Ochs K, Floer M, Strauss M, Rennebaum F, Kabar I, Rovas A, Nowacki T. Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis. Viruses 2021;13:2324. [PMID: 34835130 DOI: 10.3390/v13112324] [Reference Citation Analysis]
176 Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol 2021;113:45-57. [PMID: 33161508 DOI: 10.1007/s12185-020-03029-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
177 Lee C, Choi WJ. Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective. Arch Pharm Res 2021;44:99-116. [PMID: 33398692 DOI: 10.1007/s12272-020-01301-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 18.0] [Reference Citation Analysis]
178 Shehata GA, Lord KC, Grudzinski MC, Elsayed M, Abdelnaby R, Elshabrawy HA. Neurological Complications of COVID-19: Underlying Mechanisms and Management. Int J Mol Sci 2021;22:4081. [PMID: 33920904 DOI: 10.3390/ijms22084081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
179 Dupont A, Rauch A, Staessens S, Moussa M, Rosa M, Corseaux D, Jeanpierre E, Goutay J, Caplan M, Varlet P, Lefevre G, Lassalle F, Bauters A, Faure K, Lambert M, Duhamel A, Labreuche J, Garrigue D, De Meyer SF, Staels B, Vincent F, Rousse N, Kipnis E, Lenting P, Poissy J, Susen S; Lille Covid Research Network (LICORNE). Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19. Arterioscler Thromb Vasc Biol 2021;41:1760-73. [PMID: 33626910 DOI: 10.1161/ATVBAHA.120.315595] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
180 Lewis K, Stoll A, Watts S, Kirkman E. Relating Ventilatory Support and Drug Treatment Strategies to the Fundamental Pathophysiology in COVID-19 Illness. EMJ. [DOI: 10.33590/emj/20-00269] [Reference Citation Analysis]
181 Zaky S, Fathelbab HK, Elbadry M, El-raey F, Abd-elsalam SM, Makhlouf HA, Makhlouf NA, Metwally MA, Ali-eldin F, Hasan AA, Alboraie M, Yousef AM, Shata HM, Eid A, Asem N, Khalaf A, Elnady MA, Elbahnasawy M, Abdelaziz A, Shaltout SW, Elshemy EE, Wahdan A, Hegazi MS, Abdel Baki A, Hassany M. Egyptian Consensus on the Role of Lung Ultrasonography During the Coronavirus Disease 2019 Pandemic. IDR 2022;Volume 15:1995-2013. [DOI: 10.2147/idr.s353283] [Reference Citation Analysis]
182 Fang L, Zhou L, Tamm M, Roth M. OM-85 Broncho-Vaxom®, a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells. Biomedicines 2021;9:1544. [PMID: 34829773 DOI: 10.3390/biomedicines9111544] [Reference Citation Analysis]
183 Al-Benna S. Failure of Free Flaps in Head and Neck Oncology Surgery in COVID-19 Patients. Plast Reconstr Surg 2021;147:900e-1e. [PMID: 33878099 DOI: 10.1097/PRS.0000000000007847] [Reference Citation Analysis]
184 Tran VL, Parsons S, Varela CR. The Trilogy of SARS-CoV-2 in Pediatrics (Part 3): Thrombosis, Anticoagulant, and Antiplatelet Considerations. J Pediatr Pharmacol Ther 2021;26:565-76. [PMID: 34421405 DOI: 10.5863/1551-6776-26.6.565] [Reference Citation Analysis]
185 McGowan EM, Haddadi N, Nassif NT, Lin Y. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19. Int J Mol Sci 2020;21:E7189. [PMID: 33003377 DOI: 10.3390/ijms21197189] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
186 Frisoni P, Neri M, D'Errico S, Alfieri L, Bonuccelli D, Cingolani M, Di Paolo M, Gaudio RM, Lestani M, Marti M, Martelloni M, Moreschi C, Santurro A, Scopetti M, Turriziani O, Zanon M, Scendoni R, Frati P, Fineschi V. Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-α. Forensic Sci Med Pathol 2021. [PMID: 34463916 DOI: 10.1007/s12024-021-00414-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Xiong X, Chi J, Gao Q. Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis. Thromb J 2021;19:32. [PMID: 34011381 DOI: 10.1186/s12959-021-00284-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
188 García de Guadiana-Romualdo L, Calvo Nieves MD, Rodríguez Mulero MD, Calcerrada Alises I, Hernández Olivo M, Trapiello Fernández W, González Morales M, Bolado Jiménez C, Albaladejo-Otón MD, Fernández Ovalle H, Conesa Hernández A, Azpeleta Manrique E, Consuegra-Sánchez L, Nogales Martín L, Conesa Zamora P, Andaluz-Ojeda D. MR-proADM as marker of endotheliitis predicts COVID-19 severity. Eur J Clin Invest 2021;51:e13511. [PMID: 33569769 DOI: 10.1111/eci.13511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
189 Sansone A, Mollaioli D, Limoncin E, Ciocca G, Bắc NH, Cao TN, Hou G, Yuan J, Zitzmann M, Giraldi A, Jannini EA. The Sexual Long COVID (SLC): Erectile Dysfunction as a Biomarker of Systemic Complications for COVID-19 Long Haulers. Sex Med Rev 2021:S2050-0521(21)00085-8. [PMID: 34933829 DOI: 10.1016/j.sxmr.2021.11.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
190 Campos-Murguía A, Román-Calleja BM, González-Regueiro JA, Hurtado-Díaz-de-León I, Solís-Ortega AA, Flores-García NC, García-Juárez I, Ruiz-Margáin A, Macías-Rodríguez RU. Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19. World J Gastroenterol 2021; 27(33): 5502-5519 [PMID: 34588748 DOI: 10.3748/wjg.v27.i33.5502] [Reference Citation Analysis]
191 Mohamed DZ, Ghoneim MES, Abu-Risha SES, Abdelsalam RA, Farag MA. Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management. World J Gastroenterol 2021; 27(28): 4504-4535 [PMID: 34366621 DOI: 10.3748/wjg.v27.i28.4504] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Meizoso JP, Moore HB, Moore EE. Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications. J Am Coll Surg 2021;232:995-1003. [PMID: 33766727 DOI: 10.1016/j.jamcollsurg.2021.02.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
193 Rommasi F, Nasiri MJ, Mirsaeidi M. Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features. Mol Cell Biochem 2022. [PMID: 35013850 DOI: 10.1007/s11010-021-04325-9] [Reference Citation Analysis]
194 Bristogiannis S, Swan D, Thachil J. Thromboprophylaxis in COVID-19 - Rationale and considerations. Adv Biol Regul 2021;81:100819. [PMID: 34332403 DOI: 10.1016/j.jbior.2021.100819] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
195 Del Borrello G, Giraudo I, Bondone C, Denina M, Garazzino S, Linari C, Mignone F, Pruccoli G, Scolfaro C, Spadea M, Pollio B, Saracco P. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study. J Thromb Haemost 2021;19:522-30. [PMID: 33305475 DOI: 10.1111/jth.15216] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]